FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
From - National Intelligence Report
Diagnostics figure prominently in key portions of the federal budget for Fiscal Year 2017. Significant funding is devoted to precision medicine, cancer, antibiotic resistance, and…
From - National Intelligence Report
"As a result of advances in the area of genetic and genomic research and diagnostic testing, it is anticipated that the need for…
From - National Intelligence Report
The Zika virus is getting increased attention from U.S. media and the Centers for Disease Control and Prevention (CDC) now that the first case of the infection has been detected in a…